Monday, October 17, 2016 8:02:02 PM
EPS has continued to improve at a rapid rate. Revs are growing at a record clip. All subsidiaries are generating higher revs QUARTER over QUARTER.
Cash on hand for next acquisition and expansion. Zero dilution for past several quarters. Platform is set perfectly for CALI green rush.
CANN has a proven management team with top Fund Manager Boockvar on board of directors.
Management has already stated CALI is a market they will tap into.
CANN has a small trading float of just 9.2m, which suggests the stock could launch higher on any additional influx of interest. And the company is making real money, with trailing twelve month revs already coming in at $2.67M, on quarterly y/y revs increasing at 64% according to the company’s latest 10-Q. While we normally reserve very little mercy for our interpretation of rallies driven solely by paid promotional materials, this does not fit that description. We would wait until November 9 to act on bearish instincts here
http://oracledispatch.com/2016/10/15/dont-fade-trend-general-cannabis-corp-otcmktscann/
Recent CANN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2023 09:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:30:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:51:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 09:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 08:33:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:30:37 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM